Table 3. Logistic Regression Analyses for 90-Day Postoperative Outcome Variables.
| Variable | OR (95% CI) | |||||
|---|---|---|---|---|---|---|
| Any Complication | P Value | Emergency Department Visit | P Value | Readmission | P Value | |
| Subtotal Colectomy or Total Abdominal Colectomy | ||||||
| Anti-TNF agent use | 0.86 (0.62-1.18) | .35 | 0.73 (0.53-1.00) | .052 | 0.82 (0.60-1.11) | .20 |
| Age, 10-y increase | 0.96 (0.87-1.06) | .40 | 0.89 (0.81-0.98) | .02 | 0.80 (0.72-0.88) | <.001 |
| Female | 1.31 (1.01-1.71) | .045 | 1.18 (0.91-1.52) | .22 | 1.02 (0.79-1.32) | .87 |
| CCI, 1-point increase | 0.99 (0.87-1.11) | .83 | 1.11 (0.99-1.25) | .07 | 1.17 (1.04-1.31) | .007 |
| Malnutrition | 1.12 (0.68-1.83) | .65 | 1.03 (0.63-1.67) | .91 | 0.96 (0.58-1.56) | .87 |
| Failure to thrive | 1.14 (0.66-1.92) | .64 | 1.05 (0.62-1.76) | .85 | 1.37 (0.82-2.28) | .23 |
| Corticosteroid use | 0.94 (0.72-1.25) | .69 | 1.26 (0.96-1.66) | .09 | 1.28 (0.98-1.68) | .07 |
| Immunomodulator use | 1.14 (0.82-1.58) | .43 | 1.13 (0.82-1.55) | .47 | 1.22 (0.89-1.68) | .22 |
| Emergency procedure | 1.19 (0.87-1.62) | .27 | 1.34 (0.99-1.80) | .06 | 1.22 (0.90-1.65) | .20 |
| Total Proctocolectomy With End Ileostomy | ||||||
| Anti-TNF agent use | 1.01 (0.59-1.70) | .98 | 0.95 (0.55-1.59) | .83 | 1.83 (1.08-3.10) | .02 |
| Age, 10-y increase | 1.06 (0.87-1.31) | .56 | 0.84 (0.69-1.03) | .10 | 0.94 (0.76-1.16) | .54 |
| Female | 1.17 (0.75-1.84) | .49 | 0.66 (0.41-1.04) | .07 | 1.22 (0.75-1.96) | .42 |
| CCI, 1-point increase | 1.05 (0.84-1.31) | .67 | 1.11 (0.89-1.39) | .36 | 0.95 (0.73-1.21) | .67 |
| Malnutrition | 0.95 (0.34-2.42) | .91 | 1.05 (0.39-2.67) | .92 | 1.65 (0.63-4.19) | .29 |
| Failure to thrive | 0.60 (0.22-1.43) | .27 | 0.41 (0.14-1.02) | .07 | 0.55 (0.19-1.37) | .23 |
| Corticosteroid use | 0.67 (0.42-1.05) | .08 | 0.88 (0.56-1.40) | .60 | 1.08 (0.66-1.75) | .76 |
| Immunomodulator use | 1.13 (0.65-1.93) | .66 | 1.07 (0.62-1.83) | .80 | 0.96 (0.54-1.68) | .89 |
| Emergency procedure | 0.92 (0.43-1.90) | .83 | 1.31 (0.63-2.66) | .46 | 0.78 (0.34-1.67) | .54 |
| Ileal Pouch-Anal Anastomosis | ||||||
| Anti-TNF agent use | 1.38 (1.05-1.82) | .02 | 0.85 (0.65-1.11) | .24 | 0.96 (0.70-1.35) | .83 |
| Age, 10-y increase | 1.07 (0.96-1.18) | .21 | 0.96 (0.87-1.06) | .38 | 0.99 (0.88-1.11) | .82 |
| Female | 1.30 (1.02-1.65) | .03 | 1.35 (1.07-1.71) | .01 | 1.37 (1.03-1.84) | .03 |
| CCI, 1-point increase | 1.05 (0.91-1.21) | .50 | 1.04 (0.91-1.20) | .55 | 1.00 (0.85-1.19) | .97 |
| Malnutrition | 1.25 (0.59-2.61) | .56 | 0.75 (0.35-1.57) | .45 | 0.73 (0.31-1.93) | .50 |
| Failure to thrive | 0.68 (0.32-1.36) | .29 | 1.03 (0.52-2.03) | .92 | 2.26 (0.91-6.87) | .11 |
| Corticosteroid use | 1.03 (0.81-1.32) | .80 | 1.26 (0.99-1.61) | .06 | 1.25 (0.93-1.68) | .14 |
| Immunomodulator use | 1.02 (0.77-1.34) | .90 | 1.11 (0.84-1.46) | .45 | 0.92 (0.66-1.28) | .61 |
| Emergency procedure | 1.47 (0.83-2.62) | .18 | 2.68 (1.48-5.07) | .002 | 1.05 (0.54-2.16) | .88 |
| Diverting stoma | 0.89 (0.66-1.22) | .47 | 1.10 (0.81-1.50) | .55 | 4.18 (3.02-5.78) | <.001 |
Abbreviations: CCI, Charlson Comorbidity Index; OR, odds ratio; TNF, tumor necrosis factor.